Resultados de búsqueda - Huiping Li
-
1
Comparison and Evaluation of Rain Gauge, CMORPH, TRMM PR and GPM DPR KuPR Precipitation Products over South China
Publicado 2025-06-01Enlace del recursoRemote sensing precipitation products are essential for the systematic analysis of precipitation characteristics and changes. This study conducts a comparative evaluation of precipitation products from rain gauge stations, Climate Prediction Center morphing technique (CMORPH), Tropical Rainfall Meas...
Artículo -
2
Experimental Archaeological Study of Incised Marks on Animal Bones Produced by Iron Implements
Publicado 2025-05-01Enlace del recursoIn zooarchaeological research, animal bone fractures can result from various processes including slaughtering, dismemberment, marrow/grease extraction, craft processing, carnivore gnawing/trampling, sediment compression, bioturbation, and recovery bias. These fractures are further influenced by bone...
Artículo -
3
Effect of AI-based pre-hospital health education via QR code on APAIS scores in patients with breast nodules: A retrospective study
Publicado 2025-08-01Enlace del recursoPurpose: To explore the effect of AI-based pre-hospital health education via QR code on preoperative anxiety and information needs in patients with breast nodules and provide a decision-making reference for ongoing optimizing clinical workflows. Methods: This retrospective study analyzed the clinica...
Artículo -
4
Identification of curcumin-inhibited extracellular matrix receptors in non–small cell lung cancer A549 cells by RNA sequencing
Publicado 2017-05-01Enlace del recursoCurcumin is a potent anti-cancer drug in several types of human cancers. Despite of several preclinical and clinical studies of curcumin, the precise mechanism of curcumin in cancer prevention has remained unclear. In our study, we for the first time investigated whole transcriptome alteration in A5...
Artículo -
5
An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 tri...
Publicado 2025-06-01Enlace del recursoAbstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with l...
Artículo